Jane Street’s BioTelemetry, Inc. BEAT Stock Holding History

Jane Street’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-38,500	Closed	-$2.77M	–	10013
2020 Q4	$2.77M	Buy	38,500 +12,900	+50%	+$675K	﹤0.01%	2928
2020 Q3	$1.17M	Buy	25,600 +18,000	+237%	+$752K	﹤0.01%	3838
2020 Q2	$343K	Sell	7,600 -10,200	-57%	-$457K	﹤0.01%	5641
2020 Q1	$685K	Buy	+17,800	New	+$819K	﹤0.01%	3284
2019 Q2	–	Sell	-6,700	Closed	-$420K	–	6152
2019 Q1	$420K	Buy	+6,700	New	+$460K	﹤0.01%	3866
2018 Q2	–	Sell	-9,500	Closed	-$295K	–	6067
2018 Q1	$295K	Buy	+9,500	New	+$312K	﹤0.01%	4041
2017 Q4	–	Sell	-10,900	Closed	-$360K	–	5594
2017 Q3	$360K	Buy	+10,900	New	+$378K	﹤0.01%	3478

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

Jane Street's BEAT Position: Q1 2021 in Review

Jane Street sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 28,429 shares — an estimated $2.05M sold.

Jane Street first reported a position in BEAT in Q2 2013 and held it in 11 quarters. The position peaked at $2.05M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

Jane Street reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
Jane Street sold 28,429 BioTelemetry, Inc. shares in Q1 2021, an estimated $2.05M.
Jane Street first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 11 quarters.
Jane Street's BioTelemetry, Inc. position peaked at $2.05M in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Jane Street's 13F filing for Q1 2021, filed 18 May 2021.